Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Progenics Pharmaceuticals Inc (PGNX)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Ardsley Partners

Philip Hempleman

650,000 $4,011 -49% 0.64%
2.
Farallon Capital

Thomas Steyer

5,543,386 $34,203 +32% 0.28%
3. 716,880 $4,423 0.25%
4. 5,858,749 $36,148 +2% 0.18%
5.
PDT Partners

Peter Muller

139,900 $863 -9% 0.05%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.99 72,023 Large Shareholder, Other 8,011,733 2019-09-09 Filing
$4.94 21,480 Large Shareholder, Other 1,950,000 2019-09-09 Filing
$4.62 43,520 Large Shareholder, Other 1,928,520 2019-09-05 Filing
$4.51 243,614 Large Shareholder, Other 7,939,710 2019-09-04 Filing
$4.39 277,424 Large Shareholder, Other 7,696,096 2019-09-03 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.55 150,000 Large Shareholder 6,997,269 2017-02-15 Filing
$9.68 150,000 Large Shareholder 7,147,269 2017-02-14 Filing
$9.70 100,000 Large Shareholder 7,297,269 2017-02-14 Filing
$9.70 50,000 Large Shareholder 7,397,269 2017-02-14 Filing
$9.70 52,600 Large Shareholder 7,447,269 2017-02-14 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,033,328 $6,376 0.68%
2. 138,357 $853 0.47%
3. 2,242,503 $13,836 0.45%
4. 472,580 $2,750 0.18%
5. 1,298,723 $8,013 0.18%
News See All